Noveris Health Sciences is trading at CA$1.45, down 5.8% today on follow-through selling after a sharp drop in the previous session.
- The stock continues its downward trend after falling from CA$1.76 to CA$1.54 yesterday, with no new company-specific news reported on July 15.
- Recent corporate activity includes a June 5 update and a June 29 AGM announcement, but no fresh earnings or regulatory catalysts have been disclosed to explain today's move.
- The decline appears to be a continuation of recent volatility rather than a reaction to a new fundamental event.